Actinium Pharmaceuticals, Inc. - Director's Dealing 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-05-31

Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-31	Common Stock	S	18110	$1.90	Disposed	5358735	Direct
2016-05-31	Common Stock	S	1890	$1.905	Disposed	5356845	Direct
2016-05-31	Common Stock	S	19700	$1.92	Disposed	5337145	Direct
2016-05-31	Common Stock	S	300	$1.9201	Disposed	5336845	Direct
2016-05-31	Common Stock	S	23837	$1.93	Disposed	5313008	Direct
2016-05-31	Common Stock	S	100	$1.9301	Disposed	5312908	Direct
2016-05-31	Common Stock	S	600	$1.9315	Disposed	5312308	Direct
2016-05-31	Common Stock	S	300	$1.935	Disposed	5312008	Direct
2016-05-31	Common Stock	S	56954	$1.94	Disposed	5255054	Direct
2016-05-31	Common Stock	S	790	$1.945	Disposed	5254264	Direct
2016-05-31	Common Stock	S	6755	$1.95	Disposed	5247509	Direct
2016-06-01	Common Stock	S	4800	$2.00	Disposed	5242709	Direct
2016-06-01	Common Stock	S	4650	$2.005	Disposed	5238059	Direct
2016-06-01	Common Stock	S	1428	$2.01	Disposed	5236631	Direct
2016-06-01	Common Stock	S	20000	$2.1	Disposed	5216631	Direct
2016-06-01	Common Stock	S	9036	$2.17	Disposed	5207595	Direct
2016-06-01	Common Stock	S	200	$2.18	Disposed	5207395	Direct